^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation

Published date:
02/11/2020
Excerpt:
...recurrence of gallbladder carcinoma (GBC) in a patient...ATM S1905Ifs*25 and STK11 K262Sfs*25 mutations were detected...He was treated with olaparib based on the medical evidence and obtained a 13‐month PFS.
DOI:
10.1634/theoncologist.2019-0498